Peer Review History

Original SubmissionJuly 10, 2023
Decision Letter - Mergan Naidoo, Editor

PONE-D-23-11849A multi-dimensional incomplete stepped-wedge trial design to estimate the impact of standards-based auditPLOS ONE

Dear Dr. Sarah Ann White

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within two weeks. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Well written and fairly explained. Just I would like to know more about considerations after those limitation points. For example, you have mentioned in line 502 (the covariate maybe considered) and that (in my opinion) will let the reader be thrilled and imagining what will these improvements do next?

Overall, Nice article

Reviewer #2: This study is highly intriguing as it employs a complex research design to investigate the impact of standards-based audits. The design incorporates multiple dimensions and utilizes a stepped-wedge trial approach. In this approach, the application of the intervention (standards-based audits) varies across different clusters, rather than being uniform. The primary objective is to estimate the effects of these audits on specific outcomes.

The study introduces an innovative trial design that avoids the common pitfalls associated with the use of before-after designs in clinical audits, which often lead to biased impact estimations. However, there are certain aspects that, in my opinion, the authors should carefully contemplate before proceeding with the publication of their work in your journal.

Neither in the introduction nor in the discussion sections did the authors clearly explain why they believe the chosen design would be more advantageous when compared to existing approaches (such as before and after designs). I would appreciate it if the authors could offer readers a comprehensive justification for the trial design and elaborate on its distinctions from the before-after design used in clinical audits. What limitations of the before-after design have influenced their preference for the trial design?

In the body text, I recommend placing tables immediately after their corresponding citations. This approach not only adheres to the journal's guidelines but also enhances the reader's comprehension flow.

I am of the opinion that there are certain writing issues that should be addressed on a line-by-line basis. For instance, in line number 115 of the manuscript, the in-text citation format appears inconsistent with other citations, and information source for Table 1 is labeled as "source:2".

Overall, this is a commendable piece of work with significant novelty, and it deserves support. If published, it has the potential to benefit numerous researchers and contribute to the ongoing improvement of our audit practices, particularly in developing countries.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: Comments-1.docx
Revision 1

Reviewer’s comment

Well written and fairly explained. Just I would like to know more about considerations after those limitation points. For example, you have mentioned in line 502 (the covariate maybe considered) and that (in my opinion) will let the reader be thrilled and imagining what will these improvements do next?

Response:

Thank you for your interest in our manuscript and your desire to know more. The point noted is a comment regarding a possible approach to the modelling of a particular circumstance. Our aim in the manuscript is to present the design and the potential value of using the design.

In the example noted we suggest a possible approach to handling a particular circumstance; the potential value of the approach would need to be explored in the context of a particular study design. We have not amended the text in response.

Reviewer’s comment:

Neither in the introduction nor in the discussion sections did the authors clearly explain why they believe the chosen design would be more advantageous when compared to existing approaches (such as before and after designs). I would appreciate it if the authors could offer readers a comprehensive justification for the trial design and elaborate on its distinctions from the before-after design used in clinical audits.

Response:

Thank you for highlighting the need to provide justification for the design and distinguish it from the before-after design. Text has been added as follows:

Lines 105-109 indicate the ways in which the SW-CRT design is related to the before-after design but also provides a mechanism for addressing any bias in estimation due to a secular trend, which the before-after design cannot do.

Lines 152-3 have been added to clarify an aspect of the extension that should be mentioned.

Reviewers comment:

What limitations of the before-after design have influenced their preference for the trial design?

Response:

Sentences have been added in lines 55-57 to indicate the limitations and line 87 has been modified.

Reviewer’s comment:

In the body text, I recommend placing tables immediately after their corresponding citations. This approach not only adheres to the journal's guidelines but also enhances the reader's comprehension flow.

Response:

The guidelines indicate that each table should be placed immediately after the paragraph in which the first citation of a table occurs. I have verified that this is how they are positioned (and inserted some page breaks to avoid tables and Figures being split across pages).

Reviewer’s comment:

I am of the opinion that there are certain writing issues that should be addressed on a line-by-line basis. For instance, in line number 115 of the manuscript, the in-text citation format appears inconsistent with other citations, and information source for Table 1 is labeled as "source:2".

Response:

Thank you for identifying these issues which have now been addressed (line 115 is now line 121).

Table 1 has been revised to acknowledge the content from the reference cited more accurately in the format used in Table 2 (as no comment was raised for Table 2 I presume it is correct; I can’t find guidance on this in the webpages).

Reviewer’s comment:

Overall, this is a commendable piece of work with significant novelty, and it deserves support. If published, it has the potential to benefit numerous researchers and contribute to the ongoing improvement of our audit practices, particularly in developing countries.

Response:

Thank you for your endorsement of the value of this work.

Editors Comment:

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response:

These have now been checked, and Figures no longer contain legends etc

Editors Comment:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references.

Response:

All references were checked on 4th Sept 2023. Some details have been revised to ensure compliance with standards for references.

The reference we numbered 1 is no longer available directly via the WHO webpages. We have therefore referenced an alternative (previously numbered 6). This change has necessitated some revision of reference numbers (one of which was identified to have been incorrect).

Attachments
Attachment
Submitted filename: Response_To_Reviewers_18Sep23.docx
Decision Letter - Mergan Naidoo, Editor

A multi-dimensional incomplete stepped-wedge trial design to estimate the impact of standards-based audit

PONE-D-23-11849R1

Dear Dr. Sarah Ann White

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mergan Naidoo, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Mergan Naidoo, Editor

PONE-D-23-11849R1

A multi-dimensional incomplete stepped-wedge trial design to estimate the impact of standards-based audit

Dear Dr. White:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Mergan Naidoo

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .